BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
249714	COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1	InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-3-2-4-11(16)5-9/h2-7,19H,8H2,1H3,(H,18,21)	LQWXMRRGVHUWEN-UHFFFAOYSA-N	107695	US8722895, 1: {[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2- carbonyl]-amino}-acetic acid methyl ester::US8598210, Table XV, 1::US9598370, Example 00126::USRE47437, Example {[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US11426393, Compound Table XV.1	Egl nine homolog 1	Homo sapiens		 2800						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107695	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107695&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891582	186524565							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249715	COC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(Cl)cc1	InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-2-4-11(16)5-3-9/h2-7,19H,8H2,1H3,(H,18,21)	BYGKIXAXITXFDW-UHFFFAOYSA-N	107696	US8722895, 2: {[5-(4-Chloro-phenyl)-3-hydroxy-pyridine- 2-carbonyl]-amino}-acetic acid methyl ester::US8598210, Table XV, 2::US9598370, Example 00127::USRE47437, Example {[5-(4-Chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US11426393, Compound Table XV.2	Egl nine homolog 1	Homo sapiens		 3700						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107696	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107696&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891583	186524566							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249716	COC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(cc1)[N+]#[C-]	InChI=1S/C16H13N3O4/c1-17-12-5-3-10(4-6-12)11-7-13(20)15(18-8-11)16(22)19-9-14(21)23-2/h3-8,20H,9H2,2H3,(H,19,22)	BTQPHDGAEFUTEH-UHFFFAOYSA-N	107697	US8722895, 3: {[5-(4-Cyano-phenyl)-3-hydroxy-pyridine-2- carbonyl]-amino}-acetic acid methyl ester::US8598210, Table XV, 3	Egl nine homolog 1	Homo sapiens		 5800						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107697	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107697&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891535	186524567							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249717	Cc1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1	InChI=1S/C15H14N2O4/c1-9-2-4-10(5-3-9)11-6-12(18)14(16-7-11)15(21)17-8-13(19)20/h2-7,18H,8H2,1H3,(H,17,21)(H,19,20)	VBNCAZJDNCXKIO-UHFFFAOYSA-N	107698	US8722895, 4: [(3-Hydroxy-5-(4-methylphenyl)pyridine-2- carbonyl)amino]-acetic acid::US8598210, Table XV, 4::US9598370, Example 00129::USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)pyridine-2-carbonyl)amino]-acetic acid::US11426393, Compound Table XV.4	Egl nine homolog 1	Homo sapiens		 650						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107698	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107698&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891734	186524568							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249718	Cc1ccc(cc1)-c1ccc(C(=O)NCC(O)=O)c(O)c1	InChI=1S/C16H15NO4/c1-10-2-4-11(5-3-10)12-6-7-13(14(18)8-12)16(21)17-9-15(19)20/h2-8,18H,9H2,1H3,(H,17,21)(H,19,20)	POKDHYRFSOQLCV-UHFFFAOYSA-N	107699	US8722895, 5: [(3-Hydroxy-4&#39;-methyl-biphenyl-4- carbonyl)-amino]-acetic acid::US8598210, Table XV, 5::US9598370, Example 00130::USRE47437, Example [(3-Hydroxy-4'-methyl-biphenyl-4-carbonyl)-amino]-acetic acid::US11426393, Compound Table XV.5	Egl nine homolog 1	Homo sapiens		 20000						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107699	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107699&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891042	186524569							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249719	COC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(C)cc1	InChI=1S/C16H16N2O4/c1-10-3-5-11(6-4-10)12-7-13(19)15(17-8-12)16(21)18-9-14(20)22-2/h3-8,19H,9H2,1-2H3,(H,18,21)	DSAKFJKYBXTHSR-UHFFFAOYSA-N	107700	US8722895, 6: [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2- carbonyl)-amino]-acetic acid methyl ester::US8598210, Table XV, 6::US9598370, Example 00131::USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2-carbonyl)-amino]-acetic acid methyl ester::US11426393, Compound Table XV.6	Egl nine homolog 1	Homo sapiens		 4100						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107700	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107700&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891584	186524570							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249720	COC(=O)CNC(=O)c1ncc(cc1O)-c1ccccc1Cl	InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-9(7-17-14)10-4-2-3-5-11(10)16/h2-7,19H,8H2,1H3,(H,18,21)	BYSUDLAKLIQTEQ-UHFFFAOYSA-N	107701	US8722895, 7: {[5-(2-Chloro-phenyl)-3-hydroxy-pyridine- 2-carbonyl]-amino}-acetic acid methyl ester::US8598210, Table XV, 7::US9598370, Example 00132::USRE47437, Example {[5-(2-Chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US11426393, Compound Table XV.7	Egl nine homolog 1	Homo sapiens		 6800						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107701	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107701&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891581	186524571							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249721	OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(cc1)[N+]#[C-]	InChI=1S/C15H11N3O4/c1-16-11-4-2-9(3-5-11)10-6-12(19)14(17-7-10)15(22)18-8-13(20)21/h2-7,19H,8H2,(H,18,22)(H,20,21)	WESRXHMJQHLLSE-UHFFFAOYSA-N	107702	US8722895, 8: {[5-(4-Cyanophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8598210, Table XV, 8	Egl nine homolog 1	Homo sapiens		 99000						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107702	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107702&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891736	186524572							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249722	OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(Cl)cc1	InChI=1S/C14H11ClN2O4/c15-10-3-1-8(2-4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)	DLUPTLSWWQTJFJ-UHFFFAOYSA-N	107703	US8722895, 9: {[5-(4-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8598210, Table XV, 9::US9598370, Example 00134::USRE47437, Example {[5-(4-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid::US10889546, US2007/0299086 Table 2.4::US11426393, Compound Table XV.9	Egl nine homolog 1	Homo sapiens		 240						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107703	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107703&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891686	186524573							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249723	OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1	InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)	JGRXMPYUTJLTKT-UHFFFAOYSA-N	107704	US8598210, Table XV, 11::US8598210, 119::US8722895, 11: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8722895, 10: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid trifluoroacetic acid salt::US8598210, Table XV, 10::US9598370, Example 00136::USRE47437, Example {[5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid::US11426393, Compound Table XV.11::US20240376089, Compound AKB-6548	Egl nine homolog 1	Homo sapiens		 410						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107704	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107704&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			23634441	186524574							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249724	OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1	InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)	JGRXMPYUTJLTKT-UHFFFAOYSA-N	107704	US8598210, Table XV, 11::US8598210, 119::US8722895, 11: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8722895, 10: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid trifluoroacetic acid salt::US8598210, Table XV, 10::US9598370, Example 00136::USRE47437, Example {[5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid::US11426393, Compound Table XV.11::US20240376089, Compound AKB-6548	Egl nine homolog 1	Homo sapiens		 1100						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107704	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107704&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			23634441	186524574							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249725	OC(=O)CNC(=O)c1ncc(cc1O)-c1ccccc1Cl	InChI=1S/C14H11ClN2O4/c15-10-4-2-1-3-9(10)8-5-11(18)13(16-6-8)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)	ULLZYMRNGQLQCT-UHFFFAOYSA-N	107706	US8722895, 12: {[5-(2-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8598210, Table XV, 12::US9598370, Example 00137::USRE47437, Example {[5-(2-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid::US11426393, Compound Table XV.12	Egl nine homolog 1	Homo sapiens		 1100						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107706	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107706&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891688	186524576							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249726	CC(C)c1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1	InChI=1S/C17H18N2O4/c1-10(2)11-3-5-12(6-4-11)13-7-14(20)16(18-8-13)17(23)19-9-15(21)22/h3-8,10,20H,9H2,1-2H3,(H,19,23)(H,21,22)	XZPLTNPEACHLGV-UHFFFAOYSA-N	107707	US8722895, 13: {[5-(4-Isopropylphenyl)-3-hydroxypyridine- 2-carbonyl]amino}-acetic acid::US8598210, Table XV, 13::US9598370, Example 00138::USRE47437, Example {[5-(4-Isopropylphenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid::US11426393, Compound Table XV.13	Egl nine homolog 1	Homo sapiens		 440						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107707	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107707&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891735	186524577							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249727	OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(F)cc1	InChI=1S/C14H11FN2O4/c15-10-3-1-8(2-4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)	XTAXWQIDORMKHA-UHFFFAOYSA-N	107708	US8722895, 14: {[5-(4-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8598210, Table XV, 14::US9598370, Example 00139::USRE47437, Example {[5-(4-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid::US11426393, Compound Table XV.14	Egl nine homolog 1	Homo sapiens		 300						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107708	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107708&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891687	186524578							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249728	CC(C)Oc1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1	InChI=1S/C17H18N2O5/c1-10(2)24-13-5-3-11(4-6-13)12-7-14(20)16(18-8-12)17(23)19-9-15(21)22/h3-8,10,20H,9H2,1-2H3,(H,19,23)(H,21,22)	XAQQOGZYOJAKKO-UHFFFAOYSA-N	107709	US8722895, 15: {[5-(4-Isopropoxyphenyl)-3- hydroxypyridine-2-carbonyl]amino}-acetic acid::US8598210, Table XV, 15::US9598370, Example 00140::USRE47437, Example {[5-(4-Isopropoxyphenyl)-3-hydroxypyridine-2-carbonyl]amino}-aceticacid::US11426393, Compound Table XV.15	Egl nine homolog 1	Homo sapiens		 1600						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107709	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107709&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24890990	186524579							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249729	Cc1ccc(Cl)cc1-c1cnc(C(=O)NCC(O)=O)c(O)c1	InChI=1S/C15H13ClN2O4/c1-8-2-3-10(16)5-11(8)9-4-12(19)14(17-6-9)15(22)18-7-13(20)21/h2-6,19H,7H2,1H3,(H,18,22)(H,20,21)	XFZFCHHQSHMUBB-UHFFFAOYSA-N	107710	US8722895, 16: {[5-(2-Methyl-5-chlorophenyl)-3- hydroxypyridine-2-carbonyl]amino}-acetic acid::US8598210, Table XV, 16::US9598370, Example 00141::USRE47437, Example {[5-(2-Methyl-5-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-aceticacid::US11426393, Compound Table XV.16	Egl nine homolog 1	Homo sapiens		 2500						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107710	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107710&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891737	186524580							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249730	CNC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1	InChI=1S/C15H14ClN3O3/c1-17-13(21)8-19-15(22)14-12(20)6-10(7-18-14)9-3-2-4-11(16)5-9/h2-7,20H,8H2,1H3,(H,17,21)(H,19,22)	FLEKXPKWSFKURA-UHFFFAOYSA-N	107711	US8722895, 17: 5-(3-Chlorophenyl)-N-(2-methylamino-2- oxoethyl)-3-hydroxypyridin-2-yl amide::US8598210, Table XV, 17::US9598370, Example 00142::USRE47437, Example 5-(3-Chlorophenyl)-N-(2-methylamino-2-oxoethyl)-3-hydroxypyridin-2-yl amide::US11426393, Compound Table XV.17	Egl nine homolog 1	Homo sapiens		 1200						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107711	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107711&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891044	186524581							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249731	COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)[N+]#[C-]	InChI=1S/C16H13N3O4/c1-17-12-5-3-4-10(6-12)11-7-13(20)15(18-8-11)16(22)19-9-14(21)23-2/h3-8,20H,9H2,2H3,(H,19,22)	UAWDTSDYMRFDAE-UHFFFAOYSA-N	107712	US8722895, 18: {[5-(3-Cyano-phenyl)-3-hydroxy-pyridine-2- carbonyl]-amino}-acetic acid methyl ester::US8598210, Table XV, 18	Egl nine homolog 1	Homo sapiens		 5100						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107712	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107712&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891633	186524582							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249732	COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)-c1nnn[nH]1	InChI=1S/C16H14N6O4/c1-26-13(24)8-18-16(25)14-12(23)6-11(7-17-14)9-3-2-4-10(5-9)15-19-21-22-20-15/h2-7,23H,8H2,1H3,(H,18,25)(H,19,20,21,22)	YSPBNSRKQJFWJL-UHFFFAOYSA-N	107713	US8722895, 19: ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)- phenyl]-pyridine-2-carbonyl}-amino)-acetic acid methyl ester::US8598210, Table XV, 19	Egl nine homolog 1	Homo sapiens		 2600						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107713	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107713&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891638	186524583							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249733	OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)[N+]#[C-]	InChI=1S/C15H11N3O4/c1-16-11-4-2-3-9(5-11)10-6-12(19)14(17-7-10)15(22)18-8-13(20)21/h2-7,19H,8H2,(H,18,22)(H,20,21)	JXJSELGVIJDMTN-UHFFFAOYSA-N	107714	US8722895, 20: {[5-(3-Cyanophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8598210, Table XV, 20::US9598370, Example 00145	Egl nine homolog 1	Homo sapiens		 190						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107714	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107714&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891733	186524584							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249734	COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C(N)=O	InChI=1S/C16H15N3O5/c1-24-13(21)8-19-16(23)14-12(20)6-11(7-18-14)9-3-2-4-10(5-9)15(17)22/h2-7,20H,8H2,1H3,(H2,17,22)(H,19,23)	MWJDKCNAPFXDPO-UHFFFAOYSA-N	107715	US8722895, 21: {[5-(3-Carbamoyl-phenyl)-3-hydroxy- pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US8598210, Table XV, 21::US9598370, Example 00146::USRE47437, Example {[5-(3-Carbamoyl-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acidmethyl ester::US11426393, Compound Table XV.21	Egl nine homolog 1	Homo sapiens		 11200						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107715	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107715&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891634	186524585							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249735	COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C(=O)N1CCCC1	InChI=1S/C20H21N3O5/c1-28-17(25)12-22-19(26)18-16(24)10-15(11-21-18)13-5-4-6-14(9-13)20(27)23-7-2-3-8-23/h4-6,9-11,24H,2-3,7-8,12H2,1H3,(H,22,26)	HBZHWXZOIFSLHR-UHFFFAOYSA-N	107716	US8722895, 22: ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)- phenyl]-pyridine-2-carbonyl}-amino)-acetic acid methyl ester::US8598210, Table XV, 22::US9598370, Example 00147::USRE47437, Example ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)-phenyl]-pyridine-2-carbonyl}-amino)-aceticacid methyl ester::US11426393, Compound Table XV.22	Egl nine homolog 1	Homo sapiens		 2500						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107716	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107716&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891635	186524586							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249736	OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C(=O)N1CCCC1	InChI=1S/C19H19N3O5/c23-15-9-14(10-20-17(15)18(26)21-11-16(24)25)12-4-3-5-13(8-12)19(27)22-6-1-2-7-22/h3-5,8-10,23H,1-2,6-7,11H2,(H,21,26)(H,24,25)	FPDULEQZUNAQKE-UHFFFAOYSA-N	107717	US8722895, 23: ({3-Hydroxy-5-[3-(pyrrolidine-1- carbonyl)phenyl]-pyridine-2- carbonyl}amino)-acetic acid::US8598210, Table XV, 23::US9598370, Example 00148::USRE47437, Example ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)phenyl]-pyridine-2-carbonyl}amino)-acetic acid::US11426393, Compound Table XV.23	Egl nine homolog 1	Homo sapiens		 300						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107717	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107717&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24890988	186524587							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249737	OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)-c1nnn[nH]1	InChI=1S/C15H12N6O4/c22-11-5-10(6-16-13(11)15(25)17-7-12(23)24)8-2-1-3-9(4-8)14-18-20-21-19-14/h1-6,22H,7H2,(H,17,25)(H,23,24)(H,18,19,20,21)	JCWZYUTUSRZUAB-UHFFFAOYSA-N	107718	US8722895, 24: ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)phenyl]- pyridine-2-carbonyl}-amino)-acetic acid::US8598210, Table XV, 24	Egl nine homolog 1	Homo sapiens		 400						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107718	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107718&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24890989	186524588							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249738	COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(NC(=O)C2CC2)c1	InChI=1S/C19H19N3O5/c1-27-16(24)10-21-19(26)17-15(23)8-13(9-20-17)12-3-2-4-14(7-12)22-18(25)11-5-6-11/h2-4,7-9,11,23H,5-6,10H2,1H3,(H,21,26)(H,22,25)	NJTATWKWAORKQP-UHFFFAOYSA-N	107719	US8722895, 25: ({5-[3-(cyclopropanecarbonyl-amino)- phenyl]-3-hydroxy-pyridine-2-carbonyl}- amino)-acetic acid methyl ester::US8598210, Table XV, 25::US9598370, Example 00150::USRE47437, Example ({5-[3-(Cyclopropanecarbonyl-amino)-phenyl]-3-hydroxy-pyridine-2-carbonyl}-amino)-acetic acid methyl ester::US11426393, Compound Table XV.25	Egl nine homolog 1	Homo sapiens		 9200						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107719	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107719&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search			24891682	186524589							1	MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF	6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI	Egl nine homolog 1	EGLN1_HUMAN	Q9GZT9	Q8N3M8 Q9BZS8 Q9BZT0		hypoxia-inducible factor-proline dioxygenase	R4SCQ0_HUMAN	R4SCQ0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
249739	COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1	InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-3-2-4-11(16)5-9/h2-7,19H,8H2,1H3,(H,18,21)	LQWXMRRGVHUWEN-UHFFFAOYSA-N	107695	US8722895, 1: {[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2- carbonyl]-amino}-acetic acid methyl ester::US8598210, Table XV, 1::US9598370, Example 00126::USRE47437, Example {[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US11426393, Compound Table XV.1	Prolyl hydroxylase EGLN3	Homo sapiens		 21400						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107695	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107695&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			24891582	186524565							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
249740	Cc1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1	InChI=1S/C15H14N2O4/c1-9-2-4-10(5-3-9)11-6-12(18)14(16-7-11)15(21)17-8-13(19)20/h2-7,18H,8H2,1H3,(H,17,21)(H,19,20)	VBNCAZJDNCXKIO-UHFFFAOYSA-N	107698	US8722895, 4: [(3-Hydroxy-5-(4-methylphenyl)pyridine-2- carbonyl)amino]-acetic acid::US8598210, Table XV, 4::US9598370, Example 00129::USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)pyridine-2-carbonyl)amino]-acetic acid::US11426393, Compound Table XV.4	Prolyl hydroxylase EGLN3	Homo sapiens		 180						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107698	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107698&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			24891734	186524568							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
249741	COC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(C)cc1	InChI=1S/C16H16N2O4/c1-10-3-5-11(6-4-10)12-7-13(19)15(17-8-12)16(21)18-9-14(20)22-2/h3-8,19H,9H2,1-2H3,(H,18,21)	DSAKFJKYBXTHSR-UHFFFAOYSA-N	107700	US8722895, 6: [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2- carbonyl)-amino]-acetic acid methyl ester::US8598210, Table XV, 6::US9598370, Example 00131::USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2-carbonyl)-amino]-acetic acid methyl ester::US11426393, Compound Table XV.6	Prolyl hydroxylase EGLN3	Homo sapiens		 52300						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107700	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107700&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			24891584	186524570							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
249742	COC(=O)CNC(=O)c1ncc(cc1O)-c1ccccc1Cl	InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-9(7-17-14)10-4-2-3-5-11(10)16/h2-7,19H,8H2,1H3,(H,18,21)	BYSUDLAKLIQTEQ-UHFFFAOYSA-N	107701	US8722895, 7: {[5-(2-Chloro-phenyl)-3-hydroxy-pyridine- 2-carbonyl]-amino}-acetic acid methyl ester::US8598210, Table XV, 7::US9598370, Example 00132::USRE47437, Example {[5-(2-Chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US11426393, Compound Table XV.7	Prolyl hydroxylase EGLN3	Homo sapiens		 37500						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107701	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107701&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			24891581	186524571							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
249743	OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(cc1)[N+]#[C-]	InChI=1S/C15H11N3O4/c1-16-11-4-2-9(3-5-11)10-6-12(19)14(17-7-10)15(22)18-8-13(20)21/h2-7,19H,8H2,(H,18,22)(H,20,21)	WESRXHMJQHLLSE-UHFFFAOYSA-N	107702	US8722895, 8: {[5-(4-Cyanophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8598210, Table XV, 8	Prolyl hydroxylase EGLN3	Homo sapiens		 560						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107702	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107702&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			24891736	186524572							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
249744	OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(Cl)cc1	InChI=1S/C14H11ClN2O4/c15-10-3-1-8(2-4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)	DLUPTLSWWQTJFJ-UHFFFAOYSA-N	107703	US8722895, 9: {[5-(4-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8598210, Table XV, 9::US9598370, Example 00134::USRE47437, Example {[5-(4-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid::US10889546, US2007/0299086 Table 2.4::US11426393, Compound Table XV.9	Prolyl hydroxylase EGLN3	Homo sapiens		 83						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107703	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107703&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			24891686	186524573							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
249745	OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1	InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)	JGRXMPYUTJLTKT-UHFFFAOYSA-N	107704	US8598210, Table XV, 11::US8598210, 119::US8722895, 11: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8722895, 10: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid trifluoroacetic acid salt::US8598210, Table XV, 10::US9598370, Example 00136::USRE47437, Example {[5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid::US11426393, Compound Table XV.11::US20240376089, Compound AKB-6548	Prolyl hydroxylase EGLN3	Homo sapiens		 390						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107704	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107704&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			23634441	186524574							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
249746	OC(=O)CNC(=O)c1ncc(cc1O)-c1ccccc1Cl	InChI=1S/C14H11ClN2O4/c15-10-4-2-1-3-9(10)8-5-11(18)13(16-6-8)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)	ULLZYMRNGQLQCT-UHFFFAOYSA-N	107706	US8722895, 12: {[5-(2-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US8598210, Table XV, 12::US9598370, Example 00137::USRE47437, Example {[5-(2-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid::US11426393, Compound Table XV.12	Prolyl hydroxylase EGLN3	Homo sapiens		 390						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107706	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107706&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			24891688	186524576							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
249747	CNC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1	InChI=1S/C15H14ClN3O3/c1-17-13(21)8-19-15(22)14-12(20)6-10(7-18-14)9-3-2-4-11(16)5-9/h2-7,20H,8H2,1H3,(H,17,21)(H,19,22)	FLEKXPKWSFKURA-UHFFFAOYSA-N	107711	US8722895, 17: 5-(3-Chlorophenyl)-N-(2-methylamino-2- oxoethyl)-3-hydroxypyridin-2-yl amide::US8598210, Table XV, 17::US9598370, Example 00142::USRE47437, Example 5-(3-Chlorophenyl)-N-(2-methylamino-2-oxoethyl)-3-hydroxypyridin-2-yl amide::US11426393, Compound Table XV.17	Prolyl hydroxylase EGLN3	Homo sapiens		 1300						25.00 C	US Patent		10.7270/Q25Q4TRQ		aid1800447	US8722895	Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC	5/13/2014	10/20/2014	Akebia Therapeutics	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107711	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107711&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search			24891044	186524581							1	MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED		Prolyl hydroxylase EGLN3	EGLN3_HUMAN	Q9H6Z9	Q2TA79 Q3B8N4 Q6P1R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
